baber/WOPTO huggingface dataset:
Patent WO-2024010723-A1 (WO)
Inventor: CAO JINBAO
IPC: C08F2/10
Filed: 2023-06-28
Abstract: An aqueous emulsion composition useful as a binder for a non-aqueous battery electrode is provided. The composition includes a copolymer and an anionic surfactant that includes a sulfonate group or acid or salt form thereof. The anionic surfactant is not polymerizable with the copolymer. The copolymer includes as polymerized monomers: an ethylenically unsaturated ionic monomer including a phosphate or phosphonate group or salt or acid forms thereof; an ethylenically unsaturated ionic monomer including a sulfonate group or salt or acid forms thereof; a non-ionic monoethylenically unsaturated monomer; optionally an ethylenically unsaturated ionic monomer including a carboxylate group or salt or acid or anhydride form thereof; and optionally a monomer having at least two ethylenic unsaturations. A slurry composition including the aqueous emulsion composition and an active material is also provided.
Patent WO-2024025837-A1 (WO)
Title: Appareil de traitement de fluide présentant une atténuation de stratification d'entrée/de sortie de rotor et capteur de détection de paramètre présentant une meilleure précision
Inventor: GITTERMAN AMIT
IPC: F24F3/14
Filed: 2023-07-24
Abstract: L'invention concerne un système de traitement de fluide qui comprend un rotor ayant des segments de traitement et de régénération, un dispositif de chauffage, un dispositif de soufflage disposé sur un côté du rotor pour provoquer le mouvement de flux de fluide de régénération ou de traitement, un premier capteur de température comprenant plusieurs premiers éléments de détection de température, un second capteur de température comprenant au moins un second élément de détection de température, un dispositif de commande pour commander le rotor, le dispositif de chauffage ou le dispositif de soufflage sur la base de première et seconde informations de température provenant des premier et second capteurs de température, et une section déflecteur disposée sur l'autre côté du rotor pour perturber le flux de fluide de régénération ou de traitement. La section déflecteur comprend au moins trois plaques de déflecteur opposées disposées de manière transversale à une direction d'écoulement primaire du flux de fluide, les extrémités distales des plaques de déflecteur s'étendant dans le flux de fluide de façon à empêcher une ligne de visée directe à travers la section déflecteur.
Patent WO-2023137299-A1 (WO)
Title: Novel zero-contact edge detection method for estimation of realtime angular positions and angular velocities of a rotating structure with application to rotating structure vibration measurement
Inventor: ZHU WEIDONG
IPC: G01D5/26
Filed: 2023-01-11
Abstract: The present invention relates to zero-contact methods of detecting edges of rotating structures, said methods carried out without attaching an encoder or mark to the rotating structure. The methods were developed for use with image-based tracking continuously scanning laser vibrometer (CSLV) systems for tracking and scanning a rotating structure, using a one-dimensional (1D) or two-dimensional (2D) scan scheme, for vibration measurement and modal parameter identification.
Patent WO-2023192748-A1 (WO)
Title: Operation mode selection and synchronization for converged devices
Inventor: ZADOK DANNY
IPC: H04W88/06
Filed: 2023-03-07
Abstract: A converged device including a first subsystem (104) and a second subsystem (106), configured to operate in multiple operation modes with varying levels of security. One example provides a method (400) for operating the device. The method (400) includes determining, during a startup sequence (612) of the first subsystem (104) and with a first processor of the first subsystem (104), a last operation mode for the first subsystem (104). The method (400) includes determining, responsive to detecting that a SIM (230) is installed in the converged device, a network type (280) for the SIM (230). The method (400) includes controlling, with the first processor, a first communication interface (225) based on the network type (280) and the last operation mode. The method (400) includes determining, during a startup sequence (612) of the second subsystem (106) and with a second processor of the second subsystem (106), the last operation mode for the first subsystem (104) and controlling, with the second processor, a second communication interface (225) based on the last operation mode.
Patent WO-2023239988-A1 (WO)
Inventor: MARCANTEL DERRICK
IPC: B23H9/10
Filed: 2023-05-04
Abstract: L'invention concerne un système de réparation destiné à être utilisé dans la réparation d'un élément, qui comprend un outil de réparation allongé ayant une première extrémité qui supporte une électrode et une seconde extrémité opposée à la première extrémité. Une caméra a un champ de vision et est fixée de manière fixe à l'outil de réparation allongé de telle sorte que l'électrode se trouve dans le champ de vision. Une alimentation électrique est couplée à l'électrode et est conçue pour délivrer un courant électrique à l'électrode, le courant électrique étant suffisant pour former un arc entre l'électrode et l'élément pour retirer du matériau de l'élément, la seconde extrémité de l'outil de réparation allongé étant mobile pour positionner l'électrode dans une position souhaitée.
Patent WO-2024026316-A1 (WO)
Inventor: KEISER DYLAN J
IPC: C12N15/11
Filed: 2023-07-25
Abstract: The disclosure relates to compositions comprising and methods of administration to a mammal of single guide RNA (sgRNA), tracrRNA and/or crRNA used individually or in combination with one another or Cas system components in order to treat African Swine Fever Virus (ASFV). The disclosure also relates to systems for assaying therapeutically effective amounts of nucleic acid and protein that inhibit ASFV replication. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Patent WO-2020124099-A1 (WO)
Inventor: DU RAND ANDRE
IPC: F23K5/14
Filed: 2019-12-11
Abstract: The invention provides a shut-off valve (10) for a hydrocarbon liquid or fuel intake. The valve includes a first float body (14) configured to float at the surface of hydrocarbon fuel (15), a fuel intake (16) located on the first float (14) and positioned such that the intake (16) is below the surface of the fuel (15), in use, and a second float body (18) configured to float on water (20) and sink in hydrocarbon fuel (15) such that the body (18) floats at an interface of hydrocarbon fuel (15) and water (20) phases, in use. A closing means (24) is located on the second float (18) for closing or restricting the fuel intake (16) when the first float (14) and second float (18) are in contact or in close proximity and further includes a guide arrangement (26) for guiding the first and second float (14, 18) towards each other as the surface of the hydrocarbon fuel (15) approaches the fuel water interface.
Patent PH-12014500281-A1 (PH)
Title: Compounds as tyrosine kinase modulators
Inventor: XIALING GUO
IPC: C07D401/14
Filed: 2014-02-03
Abstract: The present invention is directed to novel compounds of Formula (I). The compounds of the present invention are potent tyrosine kinase modulators, and are suitable for the treatment and prevention of diseases and conditions related to abnormal activities of tyrosine kinase receptors.
Patent PH-12014501315-A1 (PH)
Title: Systems and methods for transmitting and receiving discovery and paging messages
Inventor: HEMANTH SAMPATH
IPC: H04W68/00
Filed: 2014-06-10
Abstract: Methods, devices, and computer program products for transmitting and receiving discovery and paging messages are described herein. In one aspect, an apparatus operable in a wireless communication system includes a transmitter and receiver. The transmitter transmits a discovery packet during a first discovery interval of a plurality of discovery intervals. The discovery packet advertises a service provided in a wireless communications network, and the plurality of discovery intervals include recurring time intervals when a plurality of devices are configured to transmit and receive discovery packets. The receiver receives a paging packet from a first device during a first paging interval of a plurality of paging intervals. The paging packet indicates interest in the service, and the plurality of paging intervals include recurring time intervals when the plurality of devices are configured to transmit and receive paging packets. The plurality of paging intervals do not overlap the plurality of discovery intervals.
Patent PH-12015000341-A1 (PH)
Title: Automated rain gauge
Inventor: CAPISTRANO AILON OLIVER V
IPC: G01S3/00
Filed: 2015-10-08
Abstract: The invention relates to an automated rain gauge equipped with a microcontroller (4) and ultrasonic distance sensor (7) for collecting rainfall data and GSM/GPRS shield for data transmission. Typically, precipitation data from a standard rain gauge are collected manually where constraints of having infrequent/irregular data collection and human error are highly probable and will affect the validity and accuracy of the weather data. Although automated recording rain gauges already exist, none of which adopted the original design of the standard 8" rain gauge which still is the widely accepted and most reliable design and method of rainfall measurement.
Patent PH-12015500379-A1 (PH)
Title: Engine fuel enhancement management system
Inventor: BILL MATAR WILLIAM
IPC: F02B43/08
Filed: 2015-02-20
Abstract: A system (10) for managing the addition of a fuel additive to an engine (202) which receives a conventional fuel, the system (10) comprising, a storage means (12) for storing the fuel additive, a supply line (15) communicating the storage means (12) to the engine (202), and a control valve (26) for controlling the rate of addition of the fuel additive from the storage means (12) to the engine (202).
Patent PH-12015500551-A1 (PH)
Title: Tricyclic quinoline and quinoline derivatives
Inventor: HANNES KOOLMAN
IPC: C07D487/06
Filed: 2015-03-13
Abstract: The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.
Patent PH-12015500917-A1 (PH)
Title: Method and apparatus for encoding video by using block merging, and method and apparatus for decoding video by using block merging
Inventor: TAMMY LEE
Filed: 2015-04-23
Abstract: A method of encoding a video by using block merging. The method includes: determining an encoding mode indicating a current data unit for encoding of a picture and an encoding method including prediction encoding performed for each data unit, determining an occurrence of merging with at least one neighboring data unit based on at least one of the encoding mode and a prediction mode according to the data units, determining prediction mode information, merging related information, and prediction related information, and determining encoding information of the data unit including the prediction mode information, the merging related information, and the prediction related information.
Patent PH-12015501598-A1 (PH)
Title: Spiro-lactam nmda receptor modulators and uses thereof
Inventor: LOWE JOHN A
IPC: A61K31/40
Filed: 2015-07-20
Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Patent PH-12015501664-A1 (PH)
Title: Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
Inventor: TACHDJIAN CATHERINE
IPC: A23L27/20
Filed: 2015-07-27
Abstract: The present invention relates to the discovery that certain non-naturally occurring, non-peptide arride compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or trite enhancer, more particularly, savory (the 'umami' taste of monosodium glutamate) or sweet taste modifiers, - savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.
Patent PH-12015502391-A1 (PH)
Title: Peptide compound
Inventor: TAIJI ASAMI
IPC: C07K14/605
Filed: 2015-10-14
Abstract: The present invention provides a novel peptide compound having an activating action on GLP-1 receptors and GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a partial sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P1-Tyr-Aib-Glu-Gly-Thr-alphaMePhe-Thr-Ser-Asp-Tyr-A11-A12-A13-Leu-Asp-A16-A17-Ala-Gln-A20-Glu-Phe-Val-Lys-Trp-Leu-Leu-Lys-A29 (I) wherein each symbol is as defined herein.
Patent PH-12015502601-A1 (PH)
Title: ANTI-TNF-a/CXCL10 DOUBLE-TARGETING ANTIBODY AND USE THEREOF
Inventor: HEUN-SOO KANG
IPC: A61K39/395
Filed: 2015-11-23
Abstract: The present invention relates to a TNF-a (tumor necrosis factor-alpha)/CXCL-10 (C-X-C motif chemokine 10) double targeting antibody based on the IgG format. Specifically, it was verified that an antibody, in which scFv having a heavy chain variable region and a light chain variable region of the CXCL10 specific antibody binds to the C-terminus of the heavy chain variable region of the TNF-a specific antibody, is a bispecific antibody that effectively binds to both TNF-a and CXCL10, and thus the antibody can be useful as a double targeting antibody capable of identifying TNF-a/CXCL10. A composition of the present invention comprises a TNF-a/CXCL-10 double targeting antibody which effectively binds to both TNF-a and CXCL10. The double targeting antibody of the present invention has excellent TNF-a inhibitory activity and osteoclast differentiation inhibitory activity compared with the TNF-a or CXCL10 single targeting antibody. The composition of the present invention can be used in preventing or treating immunological disease.
Patent PH-12016500164-A1 (PH)
Title: Therapeutically active compounds and their methods of use
Inventor: AGRESTA SAMUEL V
IPC: A61K31/5377
Filed: 2016-01-22
Abstract: Provided are isocitrate dehydrogenase 2 (IDH2) inhibitor compounds useful for treating cancer and methods of treating cancer, comprising administering to a subject in need thereof a compound described herein. Also provided are polymorphic forms of the IDH2 inhibitor compounds characterized by X Ray powder diffraction patterns, having improved physicochemical properties that influence in vivo dissolution rate for formulation purposes.
Patent PH-12016500962-A1 (PH)
Title: Display of information on a head mounted display
Inventor: DAVID NGUYEN
IPC: G09G5/00
Filed: 2016-05-24
Abstract: A method comprising precluding display of information on a head mounted display worn by a user, receiving information indicative of an eye orientation of the user, receiving information indicative of a head orientation of the user, determining that a difference between the eye orientation and a centered eye orientation exceeds a threshold eye orientation difference, determining that a difference between the head orientation and an anatomical position head orientation exceeds a threshold head orientation difference, and causing display of a representation of information on the head mounted display based, at least in part, on the determination that the eye orientation exceeds the threshold eye orientation difference from the centered eye orientation and the determination that the head orientation exceeds the threshold head orientation difference from the anatomical position head orientation is disclosed.
Patent PH-12016502055-A1 (PH)
Title: Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
Inventor: SAGAR THAKKAR
IPC: A23C9/00
Filed: 2016-10-17
Abstract: Delivery mode specific synthetic nutritional compositions for infants up to 1 month of age, more particularly up to 2 weeks of age, wherein the iodine content is adapted based on that found in HM produced for an infant of the same age born by the same delivery mode. Nutritional systems comprising said delivery mode specific synthetic nutritional compositions are also provided. (FR): L'invention concerne des compositions nutritionnelles synthetiques specifiques de mode d'administration pour nourrissons ages d'1 mois, plus specifiquement ages de 2 semaines, la teneur
Patent PH-12016502590-A1 (PH)
Title: Covalently bonded diabodies having immunoreactivity with pd-1 and lag-3, and methods of use thereof
Inventor: EZIO BONVINI
IPC: C07K16/28
Filed: 2016-12-22
Abstract: The present invention is directed to bi-specific diabodies that comprise two or more polypeptide chains and which possess at least one Epitope-Binding Site that is immunospecific for an epitope of PD-1 and at least one Epitope-Binding Site that is immunospecific for an epitope of LAG-3 (i.e., a "PD-I x LAG-3 bi-specific diabody"). More preferably, the present invention is directed to bi-specific diabodies that comprise four polypeptide chains and which possess two Epitope-Binding Sites that are immunospecific for one (or two) epitope(s) of PD-1 and two Epitope-Binding Site that are immunospecific for one (or two) epitope(s) of LAG-3 (i.e., a "PD-1 x LAG-3 bi-specific, tetra-valent diabody").
Patent PH-12017500084-A1 (PH)
Title: Vitamin b2 and its use
Inventor: SILVA ZOLEZZI IRMA
IPC: A61P3/12
Filed: 2017-01-12
Abstract: Vitamin B2, or a composition comprising vitamin B2,for use to improve insulin sensitivity and/or treat or prevent type II diabetes and/or to prevent CVD and/or a condition associated with a low insulin sensitivity and/or any of the foregoing in a subject.
Patent PH-12017501142-A1 (PH)
Title: Process and apparatus for making a fiber cement sheet
Inventor: VAN ACOLEYEN BERTRAND
IPC: B28B5/02
Filed: 2017-06-19
Abstract: The present invention relates to processes and apparatuses for producing fiber cement sheets as well as fiber cement sheets obtainable therewith. The processes according to the present invention at least comprise the steps of: (a) providing a cementitious slurry comprising fibers,(b) continuously discharging the slurry on an endless water-permeable transport belt, and (c) removing excess of water from the slurry through the water-permeable transport belt to form a fiber cement sheet with a predetermined thickness. By using a water-permeable transport belt for removing the excess of water from the fiber cement sheet,both the thickness and the density of the sheet can be accurately tuned, without resulting in a spring-back of the thickness of the sheet at the end of the production process. The present invention further relates to various uses of the fiber cement sheets obtainable by the processes of the invention in the building industry.
Patent PH-12018501957-A1 (PH)
Title: Oral care composition
Inventor: BLASCO ALESSANDRO
IPC: A61Q11/00
Filed: 2018-09-12
Abstract: An oral care composition comprising a sensitivity mitigating agent, a polymeric deposition aid, the composition having a viscosity 3 weeks from manufacture or longer of from 10,000 to 60,000 cps at 25øC.
Patent PH-12019000042-A1 (PH)
Title: Display device
Inventor: LIN HSIAO-LANG
IPC: H01L27/32
Filed: 2019-01-29
Abstract: The disclosure provides a display device, including a display unit emitting an output light having an output spectrum corresponding to a highest gray level of the display device. A maximum peak of the output spectrum from 543 nm to 780 nm is defined as a first intensity peak corresponding to a first wavelength, a difference is defined as subtracting a second intensity integral of the output spectrum from 543 nm to the first wavelength from a first intensity integral of the output spectrum from the first wavelength to 780 nm, a ratio of a third intensity integral of the output spectrum from 380 nm to 543 nm to the difference is greater than or equal to 0.5 pcnt and less than or equal to 38.0 pcnt .
Patent PH-12019501385-A1 (PH)
Title: Portable instant cooling system with controlled temperature
Inventor: HOLZWANGER MARK
IPC: F25B41/06
Filed: 2019-06-18
Abstract: Standalone and self-contained cooling systems using compressed liquid and/or gas CO2 containers positioned in an insulated or non-insulated vessel and consisting of a specially designed unit where the containers are vertically positioned in an upright or upside-down position. The liquid and/or gas CO2 coolant is then released into capillary tube(s) embedded into a heat transfer plate or heat exchanger thus leveraging the CO2 coolant properties. The temperature is controlled by a metering CO2 releasing system encompassing an electronic control device which can be operated remotely and/or via a touch screen and which sends alerts when pre-defined thresholds are exceeded. The invention's metering CO2 releasing system may be triggered by an electronic or a thermostatic valve or may be triggered manually or by an electronic solenoid. The invention's cooling system also encompasses check valves, which avoid liquid and/or gas CO2 from escaping when removing or replacing CO2 containers individually.
Patent PH-12020500375-A1 (PH)
Title: Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof
Inventor: PRASAD BRINDA
IPC: C07K16/18
Filed: 2020-02-24
Abstract: According to certain embodiments, the present disclosure provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds a Staphylococcus species target antigen and a second antigen binding domain that binds a complement component. In certain embodiments, the bispecific antigen-binding molecules of the present disclosure are capable of binding to the Staphylococcus species target antigen with an EC50 of about 10nM or less, and/or are capable of promoting complement deposition on the Staphylococcus species with an EC50 of about 10nM. The antibodies of the disclosure are useful for treating diseases in which inhibition or reduction of the growth of a Staphylococcus species is desired and/or therapeutically beneficial, for example, for treating staphylococcal infections including a skin infection, cellulitis, pneumonia, meningitis, urinary tract infection, toxic shock syndrome, endocarditis, osteomyelitis, bacteremia, or sepsis, or for preventing or treating a staphylococcus infection that occurs as a result of a surgical procedure.
Patent PH-12020550489-A1 (PH)
Title: Gene targets for nitrogen fixation targeting for improving plant traits
Inventor: TAMSIR ALVIN
IPC: C12Q1/02
Filed: 2020-04-24
Abstract: Methods and systems are provided for generating and utilizing a genetically engineered bacterium comprising a modification in glnD, wherein said modification is selected from the group consisting of: deletion of the entire gene, deletion of substantially the entire gene, deletion of an ACT domain, deletion of more than 50 pcnt of an ACT domain, deactivation of an ACT domain, and deactivation of an UTase domain.
Patent PH-12020551642-A1 (PH)
Title: Aav compositions, methods of making and methods of use
Inventor: TRURAN RICHARD
IPC: C12N15/864
Filed: 2020-10-05
Abstract: Disclosed are methods for the purification of a recombinant AAV (rAAV) particle from a mammalian host cell culture. The disclosure further provides a pharmaceutical composition produced by the methods of the disclosure, pharmaceutical compositions and method of using the pharmaceutical compositions described herein for the treatment of disease.